References
- Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al (2009). Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet, 41, 986-90. https://doi.org/10.1038/ng.429
- Ben Q, Wang K, Yuan Y, Li Z (2011). Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer, 128, 1179-86. https://doi.org/10.1002/ijc.25426
- Conlon KC, Klimstra DS, Brennan MF (1996). Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg, 223, 273-9. https://doi.org/10.1097/00000658-199603000-00007
- Dandona M, Gao F, Linehan DC, Wang-Gillam A (2009). Re:ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 102, 135-7.
- Engin H, Bilir C, Ustun H, Gökmen A (2012). ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev, 13, 131-3. https://doi.org/10.7314/APJCP.2012.13.1.131
- Greer JB, Yazer MH, Raval JS, et al (2010). Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol, 16, 5588-91. https://doi.org/10.3748/wjg.v16.i44.5588
- Hakomori S (1989). Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res, 52, 257-331. https://doi.org/10.1016/S0065-230X(08)60215-8
- Hakomori S (1999). Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta, 1473, 247-66. https://doi.org/10.1016/S0304-4165(99)00183-X
- Halvorsen TB (1986). ABO blood groups, rhesus types, and colorectal adenocarcinoma. A retrospective study of 747 cases. Scand J Gastroenterol, 21, 979-83. https://doi.org/10.3109/00365528608996408
- Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50. https://doi.org/10.1016/j.ejca.2010.08.009
- Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 59, 225-49. https://doi.org/10.3322/caac.20006
- Lowenfels AB, Maisonneuve P (2006). Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol, 20, 197-209. https://doi.org/10.1016/j.bpg.2005.10.001
- Slater G, Itzkowitz S, Azar S, Aufses AH Jr (1993). Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer. Dis Colon Rectum, 36, 5-7. https://doi.org/10.1007/BF02050293
- Wang DS, Wang ZQ, Zhang L, et al (2012). Are risk factors associated with outcomes in pancreatic cancer? PLoS One, 7, 41984. https://doi.org/10.1371/journal.pone.0041984
- Wolpin BM, Chan AT, Hartge P, et al (2009). ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31. https://doi.org/10.1093/jnci/djp020
Cited by
- ABO Blood Groups are Not Associated with Treatment Response and Prognosis in Patients with Local Advanced Non-Small Cell Lung Cancer vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3945
- The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-1960-7